196 related articles for article (PubMed ID: 26244572)
1. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
2. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease.
Lindeman I; Høydahl LS; Christophersen A; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM; Iversen R
Cell Rep; 2024 Apr; 43(4):114045. PubMed ID: 38578826
[TBL] [Abstract][Full Text] [Related]
3. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
4. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.
Hovhannisyan Z; Weiss A; Martin A; Wiesner M; Tollefsen S; Yoshida K; Ciszewski C; Curran SA; Murray JA; David CS; Sollid LM; Koning F; Teyton L; Jabri B
Nature; 2008 Nov; 456(7221):534-8. PubMed ID: 19037317
[TBL] [Abstract][Full Text] [Related]
5. Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.
Paolella G; Caputo I; Marabotti A; Lepretti M; Salzano AM; Scaloni A; Vitale M; Zambrano N; Sblattero D; Esposito C
PLoS One; 2013; 8(12):e84403. PubMed ID: 24391952
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in the Extraintestinal Manifestations of Celiac Disease.
Yu XB; Uhde M; Green PH; Alaedini A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30127251
[TBL] [Abstract][Full Text] [Related]
7. Expression of transglutaminase 2 in human gut epithelial cells: Implications for coeliac disease.
Amundsen SF; Stamnaes J; Lundin KEA; Sollid LM
PLoS One; 2023; 18(6):e0287662. PubMed ID: 37368893
[TBL] [Abstract][Full Text] [Related]
8. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
[TBL] [Abstract][Full Text] [Related]
9. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes.
Zanoni G; Navone R; Lunardi C; Tridente G; Bason C; Sivori S; Beri R; Dolcino M; Valletta E; Corrocher R; Puccetti A
PLoS Med; 2006 Sep; 3(9):e358. PubMed ID: 16984219
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
Siegel M; Xia J; Khosla C
Bioorg Med Chem; 2007 Sep; 15(18):6253-61. PubMed ID: 17590341
[TBL] [Abstract][Full Text] [Related]
12. Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells.
Lindeman I; Zhou C; Eggesbø LM; Miao Z; Polak J; Lundin KEA; Jahnsen J; Qiao SW; Iversen R; Sollid LM
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33095260
[TBL] [Abstract][Full Text] [Related]
13. Substrates, inhibitors, and probes of mammalian transglutaminase 2.
Zhuang R; Khosla C
Anal Biochem; 2020 Feb; 591():113560. PubMed ID: 31874171
[TBL] [Abstract][Full Text] [Related]
14. LRP-1 links post-translational modifications to efficient presentation of celiac disease-specific T cell antigens.
Loppinet E; Besser HA; Sewa AS; Yang FC; Jabri B; Khosla C
Cell Chem Biol; 2023 Jan; 30(1):55-68.e10. PubMed ID: 36608691
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.
Christophersen A; Zühlke S; Lund EG; Snir O; Dahal-Koirala S; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM
Adv Sci (Weinh); 2021 Nov; 8(21):e2102778. PubMed ID: 34495570
[TBL] [Abstract][Full Text] [Related]
16. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.
Sollid LM; Qiao SW; Anderson RP; Gianfrani C; Koning F
Immunogenetics; 2012 Jun; 64(6):455-60. PubMed ID: 22322673
[TBL] [Abstract][Full Text] [Related]
17. Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.
Kanchan K; Fuxreiter M; Fésüs L
Cell Mol Life Sci; 2015 Aug; 72(16):3009-35. PubMed ID: 25943306
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.
Myrsky E; Caja S; Simon-Vecsei Z; Korponay-Szabo IR; Nadalutti C; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Cell Mol Life Sci; 2009 Oct; 66(20):3375-85. PubMed ID: 19680746
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody binding and unique enzyme-substrate intermediate conformation of human transglutaminase 3.
Heggelund JE; Das S; Stamnaes J; Iversen R; Sollid LM
Nat Commun; 2023 Oct; 14(1):6216. PubMed ID: 37798283
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in celiac disease and refractory celiac disease.
Malamut G; Cording S; Cerf-Bensussan N
F1000Res; 2019; 8():. PubMed ID: 31297187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
